Fimasartan/Amlodipine Combination Phase III
NCT02152306 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 143
Last updated 2015-07-27
Summary
The aim of this study is to ensure the superiority of Fimasartan/Amlodipine combination in hypotensive effect after 8 weeks of treatment over Fimasartan monotherapy in patients with hypertension who have no response to Fimasartan 60mg monotherapy.
Conditions
- Essential Hypertension
Interventions
- DRUG
-
Fimasartan and Amlodipine
- DRUG
-
Fimasartan
Sponsors & Collaborators
-
Gachon University Gil Medical Center
collaborator OTHER -
The Catholic University of Korea
collaborator OTHER -
Kangbuk Samsung Hospital
collaborator OTHER -
Kyungpook National University Hospital
collaborator OTHER -
Keimyung University Dongsan Medical Center
collaborator OTHER -
Korea University Guro Hospital
collaborator OTHER -
Korea University Anam Hospital
collaborator OTHER -
DongGuk University
collaborator OTHER -
Dong-A University Hospital
collaborator OTHER -
Pusan National University Hospital
collaborator OTHER -
Seoul National University Bundang Hospital
collaborator OTHER -
Seoul National University Hospital
collaborator OTHER -
Asan Medical Center
collaborator OTHER -
Pusan National University Yangsan Hospital
collaborator OTHER -
Wonju Severance Christian Hospital
collaborator OTHER -
Gangnam Severance Hospital
collaborator OTHER -
Severance Hospital
collaborator OTHER -
Ulsan University Hospital
collaborator OTHER -
Inje University
collaborator OTHER -
Inje University Haeundae Paik Hospital
collaborator OTHER -
Chonnam National University Hospital
collaborator OTHER -
Jeju National University Hospital
collaborator OTHER -
Chungnam National University
collaborator OTHER -
Hanyang University Seoul Hospital
collaborator OTHER -
Boryung Pharmaceutical Co., Ltd
lead INDUSTRY
Principal Investigators
-
Cheol Ho Kim, Ph.D. · Seoul National University Bundang Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-04-30
- Primary Completion
- 2015-03-31
- Completion
- 2015-07-31
Countries
- South Korea
More Related Trials
-
Fimasartan in the Senior Subjects
NCT03246555 ·Status: COMPLETED ·Phase: PHASE3
-
Fimasartan Plus Amlodipine on Hemodynamic Parameters and Arterial Stiffness in Patients With Hypertension
NCT03294070 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety Study of S-Amlodipine Gentisate Compared to Amlodipine Besylate to Treat Mild-to-Moderate Hypertension
NCT00289406 ·Status: COMPLETED ·Phase: PHASE3
-
Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and Hypercholesterolemia
NCT00316095 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Stage 2 Hypertension
NCT01127217 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Efficacy and Safety Evaluation of Irbesartan High and Amlodipine Combined Therapy in Essential Hypertension Patients
NCT05475665 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate and Compare the Efficacy and Safety of AZM and AML Combined and Alone in Mild-to-moderate Essential Hypertensive Subjects
NCT05385770 ·Status: COMPLETED ·Phase: PHASE3
-
An Eight-week Randomized,Double-blind Study to Evaluate the Efficacy and Safety of Fixed-dose Combinations of T80+A5 Versus A5 Monotherapy in Patients With Hypertension Who Fail to Respond Adequately to Treatment With A5 Monotherapy
NCT01103960 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Telmisartan and Losartan in Primary Hypertension
NCT02269176 ·Status: COMPLETED ·Phase: PHASE3
-
Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant Hypertension
NCT00558428 ·Status: COMPLETED ·Phase: PHASE3
-
Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy
NCT02651870 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Efficacy and Safety Evaluation of Irbesartan and Amlodipine Combined Therapy in Essential Hypertension Patients
NCT05476354 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Essential Hypertension
NCT00940667 ·Status: COMPLETED ·Phase: PHASE3
-
Compare Efficacy and Safety of Telmisartan/Hydrochlorothiazide With Telmisartan/Hydrochlorothiazide Plus Amlodipine
NCT01911780 ·Status: COMPLETED ·Phase: PHASE3
-
Blood Pressure Lowering Effects of Amosartan Regarding Proviso iN Patients With High Blood Pressure
NCT03255551 ·Status: COMPLETED
-
Phase 2 Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential Hypetension
NCT04488978 ·Status: COMPLETED ·Phase: PHASE2
-
Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R208 and Each Monotherapy
NCT02770261 ·Status: COMPLETED ·Phase: PHASE3
-
Controlled Release Nifedipine and Valsartan Combination Therapy in Patients With Essential Hypertension
NCT01518855 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential Hypertension
NCT00940680 ·Status: COMPLETED ·Phase: PHASE3
-
Filtered Trial for Amlodipine Non-responder
NCT00558064 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension
NCT02944734 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of CKD-828 to Stage 2 Hypertension
NCT01634295 ·Status: COMPLETED ·Phase: PHASE3
-
S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in Hypertension
NCT03226340 ·Status: UNKNOWN ·Phase: PHASE4
-
Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe Hypertension
NCT00860262 ·Status: COMPLETED ·Phase: PHASE3
-
Filtered Trial for Telmisartan 40mg Non-responder
NCT00550953 ·Status: COMPLETED ·Phase: PHASE3